These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


9775 related items for PubMed ID: 1445665

  • 1. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG, Zuckerman JE, Marks JW, Rotbein J, Allen WR.
    Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
    [Abstract] [Full Text] [Related]

  • 2. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
    Rosenblum MG, Murray JL, Cheung L, Rifkin R, Salmon S, Bartholomew R.
    Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286
    [Abstract] [Full Text] [Related]

  • 3. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF, Goldmacher VS, Lambert JM, Jackson JV, McIntyre GD.
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [Abstract] [Full Text] [Related]

  • 4. Use of blue-sepharose for purification of immunotoxin containing type 1 ribosome-inactivating protein, gelonin.
    Masuda K, Hirano K, Takagishi Y.
    Biomed Chromatogr; 1994 Nov; 8(1):9-13. PubMed ID: 7510554
    [Abstract] [Full Text] [Related]

  • 5. c-erbB-2/p185-directed therapy in human lung adenocarcinoma.
    Snider JM, Bushnell LJ, Chen LC, Lanza LA.
    Ann Thorac Surg; 1996 Nov; 62(5):1454-9. PubMed ID: 8893583
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE, Brown AN, Bremner JA, Foxwell BM, Stirpe F.
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [Abstract] [Full Text] [Related]

  • 8. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
    Masuda K, Takahashi K, Nagata S, Hirano K, Takagishi Y.
    J Drug Target; 1994 Jul; 2(4):323-31. PubMed ID: 7532086
    [Abstract] [Full Text] [Related]

  • 9. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [Abstract] [Full Text] [Related]

  • 10. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
    Davol PA, Bizuneh A, Frackelton AR.
    Anticancer Res; 1999 Apr; 19(3A):1705-13. PubMed ID: 10470104
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
    Wawrzynczak EJ, Cumber AJ, Henry RV, May J, Newell DR, Parnell GD, Worrell NR, Forrester JA.
    Cancer Res; 1990 Dec 01; 50(23):7519-26. PubMed ID: 2253201
    [Abstract] [Full Text] [Related]

  • 12. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
    Rosenblum MG, Marks JW, Cheung LH.
    Cancer Chemother Pharmacol; 1999 Dec 01; 44(4):343-8. PubMed ID: 10447583
    [Abstract] [Full Text] [Related]

  • 13. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
    Mujoo K, Reisfeld RA, Cheung L, Rosenblum MG.
    Cancer Immunol Immunother; 1991 Dec 01; 34(3):198-204. PubMed ID: 1756537
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
    Goldmacher VS, Blättler WA, Lambert JM, McIntyre G, Stewart J.
    Mol Pharmacol; 1989 Nov 01; 36(5):818-22. PubMed ID: 2531272
    [Abstract] [Full Text] [Related]

  • 15. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
    Hirota N, Ueda M, Ozawa S, Abe O, Shimizu N.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7106-9. PubMed ID: 2555059
    [Abstract] [Full Text] [Related]

  • 16. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J, Junqua S, Dujardin P, Le Pecq JB, Tursz T.
    Cancer Res; 1984 Jan 15; 44(1):129-33. PubMed ID: 6690030
    [Abstract] [Full Text] [Related]

  • 17. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor.
    O'Boyle KP, Colletti D, Mazurek C, Wang Y, Ray SK, Diamond B, Rosenblum MG, Epstein AL, Shochat D, Dutcher JP.
    J Immunother Emphasis Tumor Immunol; 1995 Nov 15; 18(4):221-30. PubMed ID: 8680650
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
    Griffin TW, Pagnini PG, Houston LL.
    J Biol Response Mod; 1987 Oct 15; 6(5):537-45. PubMed ID: 3500277
    [Abstract] [Full Text] [Related]

  • 19. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU.
    Br J Cancer; 2001 Feb 15; 84(4):571-8. PubMed ID: 11207056
    [Abstract] [Full Text] [Related]

  • 20. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA, Willner D, Lasch SJ, Henderson AJ, Greenfield RS, King D, Zoeckler ME, Braslawsky GR.
    Cancer Res; 1992 Oct 15; 52(20):5693-700. PubMed ID: 1382845
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 489.